C\/EBP_NN
beta_NN
regulation_NN
of_IN
the_DT
tumor_NN
necrosis_NN
factor_NN
alpha_NN
gene_NN
._.

Activated_VBN
macrophages_NNS
contribute_VBP
to_TO
chronic_JJ
inflammation_NN
by_IN
the_DT
secretion_NN
of_IN
cytokines_NNS
and_CC
proteinases_NNS
._.

Tumor_NN
necrosis_NN
factor_NN
alpha_NN
-LRB-_-LRB-
TNF_NN
alpha_NN
-RRB-_-RRB-
is_VBZ
particularly_RB
important_JJ
in_IN
this_DT
process_NN
because_NN
of_IN
its_PRP$
ability_NN
to_TO
regulate_VB
other_JJ
inflammatory_JJ
mediators_NNS
in_IN
an_DT
autocrine_JJ
and_CC
paracrine_JJ
fashion_NN
._.

The_DT
mechanism_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
responsible_JJ
for_IN
the_DT
cell_NN
type-specific_JJ
regulation_NN
of_IN
TNF_NN
alpha_NN
is_VBZ
not_RB
known_VBN
._.

We_PRP
present_VBP
data_NNS
to_TO
show_VB
that_IN
the_DT
expression_NN
of_IN
TNF_NN
alpha_NN
is_VBZ
regulated_VBN
by_IN
the_DT
transcription_NN
factor_NN
C\/EBP_NN
beta_NN
-LRB-_-LRB-
NF-IL6_NN
-RRB-_-RRB-
._.

C\/EBP_NN
beta_NN
activated_VBD
the_DT
TNF_NN
alpha_NN
gene_NN
promoter_NN
in_IN
cotransfection_NN
assays_NNS
and_CC
bound_VBD
to_TO
it_PRP
at_IN
a_DT
site_NN
which_WDT
failed_VBD
to_TO
bind_VB
the_DT
closely_RB
related_JJ
protein_NN
C\/EBP_NN
alpha_NN
._.

Finally_RB
,_,
a_DT
dominant-negative_JJ
version_NN
of_IN
C\/EBP_NN
beta_NN
blocked_VBD
TNF_NN
alpha_NN
promoter_NN
activation_NN
in_IN
myeloid_JJ
cells_NNS
._.

Our_PRP$
results_NNS
implicate_VBP
C\/EBP_NN
beta_NN
as_IN
an_DT
important_JJ
regulator_NN
of_IN
TNF_NN
alpha_NN
by_IN
myelomonocytic_JJ
cells_NNS
._.

